Figure 2.
Bar graphs of the relative changes in the E/e’ from baseline to six months after the administration of dapagliflozin, showing that the relative changes in the E/e’ in HFpEF patients with dyslipidemia were significantly larger than those in HFpEF patients without dyslipidemia, although such finding was not observed in non-HFpEF patients. HFpEF: heart failure with preserved ejection fraction